HOME >> BIOLOGY >> NEWS
Scripps scientists discover rich medical drug resource in deep ocean sediments

Although the oceans cover 70 percent of the planet's surface, much of their biomedical potential has gone largely unexplored. Until now.

A group of researchers at Scripps Institution of Oceanography at the University of California, San Diego, have for the first time shown that sediments in the deep ocean are a significant biomedical resource for microbes that produce antibiotic molecules.

In a series of two papers, a group led by William Fenical, director of the Center for Marine Biotechnology and Biomedicine (CMBB) at Scripps Institution, has reported the discovery of a novel group of bacteria found to produce molecules with potential in the treatment of infectious diseases and cancer.

"The average person thinks of the bottom of the ocean as a dark, cold, and nasty place that is irrelevant, but we've shown that this environment may be a huge resource for new antibiotics and drugs for the treatment of cancer," said Fenical.

The first paper, published in the October, 2002 issue of Applied and Environmental Microbiology, highlights the discovery of new bacteria, called actinomycetes, from ocean sediments. For more than 45 years, terrestrial actinomycetes were the foundation of the pharmaceutical industry because of their ability to produce natural antibiotics, including important drugs such as streptomycin, actinomycin, and vancomycin. The data from this paper provide the first conclusive evidence of the widespread occurrence of indigenous actinomycete populations in marine sediments.

The second paper, published in the Jan. 20, 2003 issue of the international edition of the chemistry journal Angewandte Chemie, identifies the structure of a new natural product, which Fenical's group has named Salinosporamide A, from this new bacterial resource. The new compound is a potent inhibitor of cancer growth, including human colon carcinoma, non-small cell lung cancer, and, most effectively, breast cancer. January's report crack
'"/>

Contact: Mario Aguilera or Cindy Clark
scrippsnews@ucsd.edu
858-534-3624
University of California - San Diego
17-Jan-2003


Page: 1 2 3

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Protein believed to control formation of memory identified by Scripps & UCSD scientists
3. 22-amino acid bacterium created by Scripps scientists
4. Scripps scientists look deep inside sharks and their high-performance swimming system
5. Scripps research scientist wins 2004 Koch Prize
6. Scripps Research scientists find deafness genes function
7. New approach limits damage after heart attack and improves survival, say Scripps Research scientists
8. Scripps scientists describe dangerous cocktail of alcohol, brain peptides, and neurotransmitters
9. Chemical that turns mouse stem cells into heart muscles discovered by Scripps researchers
10. Structure solved by Scripps scientists shows one way that body controls gene expression
11. Scripps scientists say genetic mutation doesnt protect against HIV and plague

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2019)... ... September 24, 2019 , ... A-Alpha Bio ... drug development, announced today that it has raised $2.8M from leading science-focused venture ... also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen Ventures, Washington ...
(Date:9/22/2019)... LOS ANGELES (PRWEB) , ... September 20, 2019 ... ... says that instrument makers are adjusting to client demands for precision medicine products. ... that with demand exceeding $19 billion in 2018, the pharma/bio sector is the ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, LLC, ... the Medical University of Warsaw, met at the Presidential Palace of the Republic ... neuroprosthetic system as part of an initiative called "Startups in the Palace – ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... ... September 30, 2019 , ... ... from Rigaku Corporation , is now available online on the company’s global ... materials science, including X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers ...
(Date:9/24/2019)... ... September 24, 2019 , ... The Grain Foods Foundation ... Scientific Advisory Board. Dr. Holscher is an Assistant Professor of Nutrition in the ... at the University of Illinois Urbana-Champaign, where she has affiliate appointments with the ...
(Date:9/17/2019)... ... 17, 2019 , ... Geneticure, Inc., a Rochester Minnesota company ... the U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) have ... for hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics test, ...
(Date:9/11/2019)... ... September 09, 2019 , ... Tunnell Consulting, an organization ... that its president and CEO Maryann Gallivan has been accepted into the Forbes ... Council accepted Gallivan based on the role she and Tunnell Consulting ...
Breaking Biology Technology:
Cached News: